Examine publishes rigorous, unbiased analysis of the latest and most important nutrition and supplementation studies each month, available to all Examine Members. Click here to learn more or log in.
Study under review: Effect of Gliadin on Permeability of Intestinal Biopsy Explants from Celiac Disease Patients and Patients with NonCeliac Gluten Sensitivity
Introduction
As you learned in last month’s Study Deep Dives, celiac disease, wheat allergy, and non-celiac gluten sensitivity (NCGS) are distinct clinical diagnoses that share a common treatment: avoiding gluten. Confusing matters is the fact that NCGS is a diagnosis of exclusion, meaning something that's left after other possible causes have been excluded. To diagnose NCGS, wheat allergy and celiac disease (CD) must be ruled out and the person being tested must show a positive response to a gluten-free diet. Ideally, the dietary challenge would be performed in a blinded manner, as many people who believe they need a gluten-free diet may actually be suffering from a nocebo effect (when the expectation of potential problems triggers a negative effect) when undergoing a challenge. Due to these difficulties, finding pathophysiological differences between CD and NCGS has become the topic of increasing amounts of research.
Individuals with NCGS suffer adverse reactions to gluten-containing foods, though this response does not involve a T-cell (adaptive immune) mediated process. The immune system is typically divided into two categories, innate immunity offers non-specific protection like the physical barrier of the skin or immune cells that attack foreign invaders, while adaptive immunity is a response to a specific antigen which is ‘remembered’ by the body. It has been suggested[1] that the commonality between celiac disease and NCGS may actually be a shared problem of intestinal barrier function. In a healthy gut, the internal lining should be impermeable to large molecules such as gliadin (a component of gluten) due to properly functioning tight junctions, which seal off the gap between cells. However, for the past 15 years it has been known[2] that, at least in people with celiac disease, intestinal exposure to gluten, specifically gliadin, leads to an increase in intestinal permeability, which is mediated by increased release of a protein known as zonulin. Interestingly, increased intestinal permeability seems to be independent of celiac disease pathology, as many first-degree relatives of celiac patients[3] have increased permeability without having celiac disease. The genetic component of celiac disease is highlighted in Figure 1.

Cytokines[4] are proteins secreted by cells, and are one of the primary methods of cell-to-cell communication. They can be both pro-inflammatory and anti-inflammatory, and can have autocrine function (act on the cells that secrete them), paracrine function (act on nearby cells), or endocrine function (act on distant cells). In the ongoing effort to classify NCGS, cytokine secretions could potentially provide biomarkers for detecting differences among NCGS, CD, and wheat allergy.
The objectives of this study were to evaluate intestinal barrier function and cytokine secretion from intestinal biopsies of patients with CD (both active and in remission) as well as NCGS and non-celiac controls, after being exposed to partially-digested pepsin-trypsin treated gliadin (PT-gliadin, which is cytotoxic in celiac disease)[5]).
The intestinal lining of people with and sometimes without the symptoms of celiac disease can get leaky when exposed to gliadin, a component of gluten. Cytokines may play a role in this process. The goal of this study was to examine how intestinal tissue removed from the bodies of participants with celiac disease (active and in remission), participants with non-celiac gluten sensitivity (NCGS), and healthy controls respond to partially-digested gliadin.
Who and what was studied?
What were the findings?
What does the study really tell us?
The big picture
Frequently Asked Questions
What I should know?
Other Articles in Issue #08 (June 2015)
-
Metabolic flexibility: The argument to use both carbs and fats
By Mike T. Nelson, PhD
-
Blast from the past: a paleo solution for type-2 diabetes
The evidence continues to build for ancestrally-influenced diets
-
Vitamin (K)ardiovascular health?
Results are in from the first long-term trial of vitamin K2 for cardiovascular health.
-
I get by with a little help from my friends: probiotics and depression
Mix a few beneficial probiotic strains, take daily, lower your chances of depression?
-
Big breakfast or big dinner? Yet another meal-timing study
Eating the exact same meals, but in a different order could help stabilize blood sugar.
-
Green tea extract may not be an equal opportunity fat loss supplement
Does this common fat loss supplement actually work? And how might it produce its effects?
-
Interview: Shawn Wells, MPH, RD - Part 2
Shawn Wells, MPH, RD, CISSN has a unique blend of knowledge in the field of performance nutrition and supplementation. Mr. Wells attended UNC-Chapel Hill, earning a Master’s degree in Nutrition and minor in Exercise Science. His education along with credentials of Registered Dietitian, Certified Sport Nutritionist (CISSN), and board member of the ISSN, distinguished him as an expert in sports nutrition.
-
Interview: Eric Helms, PhD(c)
A go-to source for natural contest prep, Eric gives us some sage advice on macros.